Prognostic Value of Tumor Infiltrating Lymphocytes in Locally Advanced HER2 Enriched Breast Cancer.

Mostafa M Saber, Heba M El Zawahry,Amany M Hilal,Amany A Abou-Bakr,Alfred E Namour,Mona M Saber

Asian Pacific journal of cancer prevention : APJCP（2022）

引用 0|浏览0

暂无评分

摘要

High TILs is good prognosis in HER2 enriched breast cancer provided that patients received HER2 directed therapy. Moreover, CD8+ lymphocytes are highly representative and maybe used as an alternative for TILs. We recommend considering TILs and specifically CD8+ as one of the risk factors that predict prognosis of HER2+ breast cancer.

查看译文

关键词

CD8,HER2+,Trastuzumab,breast cancer,tumor infiltrating lymphocytes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要